/Companies

Athenen Therapeutics

Boston, US · Founded 2019 · Delaware corporation

Find your way into Athenen Therapeutics

Sign up to see every warm intro you have to Athenen Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Athenen Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

AL
Andrew LevinNamed on SEC filing
SR
Sarah ReedNamed on SEC filing
JS
James SchneiderNamed on SEC filing
SE
Sari EpsteinNamed on SEC filing
AR
Adam RosenbergNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$12M disclosed across 1 round · 2019

▶$12MraisedJul 2020 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew LevinDirector
  • Sarah ReedExecutive Officer
  • James SchneiderExecutive Officer
  • Sari EpsteinExecutive Officer
  • Adam RosenbergExecutive Officer, Director
Offering amount
$15M
Amount sold
$12M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Athenen Therapeutics raised?
Athenen Therapeutics has disclosed $12M raised across 1 round.
Where is Athenen Therapeutics headquartered?
Athenen Therapeutics is headquartered in Boston, US.